Table 5.
Change in Exercise Minutes (n = 40) | Change in Step Counts (n = 20) | |||
---|---|---|---|---|
Score Type | Pearson Correlation | p-value | Pearson Correlation | P-value |
EORTC QLQ-C30 | ||||
QLQ summary score | 0.19 | 0.261 | 0.54 | 0.021 |
Global health status / QoL | 0.03 | 0.865 | −0.06 | 0.813 |
Physical functioning | 0.09 | 0.589 | 0.24 | 0.344 |
Role functioning | 0.32 | 0.044 | 0.60 | 0.007 |
Emotional functioning | 0.08 | 0.638 | 0.54 | 0.016 |
Cognitive functioning | 0.20 | 0.226 | 0.43 | 0.067 |
Social functioning | −0.11 | 0.504 | 0.29 | 0.232 |
Fatigue | −0.24 | 0.142 | −0.42 | 0.074 |
Nausea and vomiting | −0.12 | 0.457 | −0.46 | 0.046 |
Pain | 0.03 | 0.846 | −0.20 | 0.409 |
Dyspnoea | −0.22 | 0.172 | −0.16 | 0.521 |
Insomnia | −0.08 | 0.616 | −0.24 | 0.332 |
Appetite loss | −0.13 | 0.439 | 0.22 | 0.365 |
Constipation | 0.10 | 0.547 | −0.54 | 0.017 |
Diarrhoea | 0.01 | 0.954 | 0.26 | 0.279 |
Financial difficulties | 0.10 | 0.562 | −0.08 | 0.758 |
MMRC Dyspnea Scale: Description of breathlessness | −0.07 | 0.683 | −0.15 | 0.568 |
PHQ-9 Total Score (omits Q10) | −0.21 | 0.220 | −0.01 | 0.962 |
*Footnote: Quality of life and symptom questionnaires were collected at week 12. Readers should note that the Intervention Group (n = 20) had increased walking distance at week 6 (but not at week 12; see Table 2)